Mark C Bagley

USPTO Granted Patents = 10 (Patent Applications = 3)

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 159(Granted Patents)

Company Filing History:

National Institutes of Health, a Component of the US Dept. of Health & Human Services

patents

1 out of 26

Centers for Disease Control and Prevention

patents

4. 1 out of 8,684

US Government As Represented by the Secretary of the Army

patents

where one patent can have more than one assignee

Years Active: 2001-2020

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10596334 - Nasal aerosol delivery system (2020-03-24),

2. 10099024 - Nasal dry powder delivery system for vaccines and other treatment agents (2018-10-16),

3. 9636460 - Pneumatic autoinjector with automated mixing (2017-05-02),

4. 9492068 - Nasal aerosol delivery system (2016-11-15),

5. 8656908 - Aerosol delivery systems and methods (2014-02-25),

6. 8544462 - Systems and methods for aerosol delivery of agents (2013-10-01),

7. 7954486 - Aerosol delivery systems and methods (2011-06-07),

8. 7699804 - Fluid ejection system (2010-04-20),

9. 7225807 - Systems and methods for aerosol delivery of agents (2007-06-05),

10. 6230539 - Ultra precision net forming process employing controlled plastic deformation of metals at elevated temperatures (2001-05-15),

Title: Innovations by Mark C. Bagley

Introduction

Mark C. Bagley is a notable inventor based in Grafton, NH (US). He has made significant contributions to the field of nasal delivery systems, holding a total of 10 patents. His work focuses on improving the delivery of treatment agents through innovative devices.

Latest Patents

One of his latest patents is a nasal aerosol delivery system. This device includes a nasal prong with openings at both the top and bottom to facilitate the passage of an aerosolized treatment agent. The activation member is strategically positioned to detect the subject's exhalation state, activating the delivery of the treatment agent upon detection. Another significant patent is for a nasal dry powder delivery system for vaccines and other treatment agents. This device features an air-receiving section with a passageway for air, a powder-reservoir receiving section, and a powder-delivery section that allows aerosolized powder to pass through. The design ensures that air exiting the device has a flattened profile for effective delivery.

Career Highlights

Mark C. Bagley has worked with reputable organizations such as Creare, Incorporated and the National Institutes of Health, a component of the US Department of Health & Human Services. His experience in these institutions has contributed to his expertise in developing innovative delivery systems.

Collaborations

Throughout his career, Bagley has collaborated with notable individuals, including James J. Barry and Mark James Papania. These collaborations have likely enhanced his research and development efforts in the field of nasal delivery systems.

Conclusion

Mark C. Bagley is a distinguished inventor whose work in nasal delivery systems has the potential to improve treatment efficacy. His innovative patents and collaborations reflect his commitment to advancing medical technology.

This text is generated by artificial intelligence and may not be accurate.